Two Distinct Strategies for HALEU Production
As the United States races to build a domestic high-assay low-enriched uranium (HALEU) supply chain, two of the primary beneficiaries of the Department of Energy's $900 million grants are taking markedly different approaches. Centrus Energy and General Matter, both backed by significant federal funding, have outlined divergent strategies for capacity expansion, technology deployment, and market entry.
Centrus Energy: The Licensed Incumbent
Centrus Energy currently holds a distinct advantage as the only US facility licensed by the Nuclear Regulatory Commission (NRC) to produce HALEU, having already produced higher-enriched uranium for nearly three years. With its DOE funding, Centrus plans to initially deliver 12 metric tons of HALEU annually. The company is also undertaking a $560 million manufacturing expansion to scale up its operations, with full capacity expected to be reached after 2030. Centrus has already secured supply contracts with advanced reactor developers Radiant, X-energy, and Antares for deliveries by the late 2020s.
General Matter: The Ambitious Challenger
In stark contrast, Peter Thiel-backed startup General Matter, led by CEO Scott Nolan, has proposed a vastly more aggressive production target. The company offered to produce 355 metric tons of HALEU annually for its $900 million award, targeting the start of operations in 2029. General Matter is developing a uranium enrichment plant at the former Superfund site in Paducah, Kentucky, applying a SpaceX-style engineering approach to solve the fuel supply bottleneck. The startup has already signed contracts with X-energy, Antares, and an unnamed utility.
General Matter proposed producing 355 metric tons of HALEU annually for its $900M DOE award, contrasting sharply with Centrus Energy's initial promise of 12 metric tons.
This article was assisted by AI analysis. Please refer to the original source for official information.